Furthermore, the research on CXCL11 in pancreatic cancer is still in the initial stage, related studies have only shown that CXCL11 is highly expressed in the serum of patients with pancreatic cancer and has a protumor function (Torres et al., 2014; Ge et al., 2020). Here, CXCL11 is linked to pancreatic neoplasm.